menu search

Monster reportedly approved to buy bang energy out of bankruptcy for $362 million

Bang Energy filed for bankruptcy in October 2022 after a jury determined it had to pay Monster $293 million for false advertising....

July 12, 2023, 3:48 pm

Broadcom-vmware merger gets european regulatory approval

Shares of Broadcom hit an all-time high after European regulators approved Broadcom's $61 billion acqui...

July 12, 2023, 12:15 pm

Europe's regulatory nod for vmware deal may lead broadcom to issue jumbo bond

News that the European Commission has approved chip maker Broadcom Inc.'s $61 billion acquisition of cl...

July 12, 2023, 11:29 am

Sec approves new rules for money market funds, critics say it will cost investors

The Securities and Exchange Commission voted Wednesday to impose new rules on money-market mutual funds in an effort to prevent potential runs on thei...

July 12, 2023, 11:20 am

Silk road medical stock tanks after cms decision on carotid artery stenting prompts analyst downgrade

Shares of Silk Road Medical Inc. SILK, -20.18% tanked 21.9% toward a more-than three-year low in premarket Tuesday, after an unfavorable government de...

July 12, 2023, 9:39 am

European commission approves broadcom's $61 billion acquisition of vmware

The European Commission has approved Broadcom Inc.'s AVGO, +0.49% acquisition of VMware Inc. VMW, +5.19...

July 12, 2023, 6:12 am

Astra space to undergo reverse stock split to shore up nasdaq listing

Billionaire-based space company Astra Space is planning a reverse stock split after its shares faced a Nasdaq delisting. The California-based company ...

July 11, 2023, 9:41 am

Blackrock's bitcoin etf filing is 'a stamp of approval', says coinshares' meltem demirors

Meltem Demirors, CoinShares chief strategy officer, joins 'Squawk Box' to discuss the state of cryptocurrency, whether a bitcoin ETF will be...

July 11, 2023, 7:35 am

India's idfc first bank says merger will boost credit growth

Last week, IDFC First Bank said its board had approved its merger with IDFC Ltd., the latest in a wave ...

July 11, 2023, 3:23 am

Guardant health: a growth company expanding its product line quickly

Guardant Health's share price has been volatile over the past year, but with strong clinical volume growth, the company presents an interesting invest...

July 10, 2023, 6:14 pm

Fda approves new alzheimer's drug but creators biogen and eisai stock slides

Eisai saw its stock fall 4.67% on the news and Biogen was down 2.07%....

July 10, 2023, 8:00 am

Biogen's alzheimer's drug rollout could be slow

Biogen has said it doesn't expect to clear a profit on Alzheimer's treatment Leqembi, which was approve...

July 7, 2023, 1:17 pm

Amazon manager who bought porsche leading $9.4m theft ring sentenced 16 years

Kayricka Wortham, a former Amazon operations manager, abused her power to submit and approve forged inv...

July 7, 2023, 12:40 pm

Eisai-biogen's alzheimer's treatment drug receives fda approval

Shares of Biogen and Eisai are lower amid news of label updates to the FDA officially approved the Alzh...

July 7, 2023, 11:15 am

Broadcom's acquisition of vmware: a major growth catalyst

Broadcom has a history of extracting significant value from its acquisitions. Regulators in the U.S., Europe, and China have yet to...

July 7, 2023, 6:14 am

Fda approves leqembi, extending alzheimer's treatment to more patients

Medicare enrollees can get the anti-amyloid treatment as a result of the agency's full approval....

July 6, 2023, 6:57 pm

First drug to slow progression of alzheimer's disease approved in us

The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzhe...

July 6, 2023, 6:44 pm

Fda approves biogen and eisai alzheimer's treatment leqembi

The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer's treatment Leqembi, a s...

July 6, 2023, 4:55 pm

Fda approves alzheimer's drug leqembi, paving way for broader medicare coverage

Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding....

July 6, 2023, 4:44 pm

Johnson & johnson: supplemental bla of carvykti gives great growth opportunity

Johnson & Johnson's Supplemental Biologics Licensing Application of CARVYKTI was filed; approval would allow company to target a much earlier Multiple...

July 6, 2023, 2:48 pm


Search within

Pages Search Results: